Pathway Analysis for Plasma β-Amyloid, Tau and Neurofilament Light (ATN) in World Trade Center Responders at Midlife
Abstract Introduction World Trade Center (WTC) responders who aided in the search and rescue efforts are now at midlife, and evidence has demonstrated that many are experiencing early-onset cognitive impairment and are at risk of developing dementia, such as Alzheimer’s disease (AD). According to th...
Main Authors: | , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Adis, Springer Healthcare
2020-04-01
|
Series: | Neurology and Therapy |
Subjects: | |
Online Access: | https://doi.org/10.1007/s40120-020-00189-1 |
id |
doaj-f4156899011c453a9c5ad18e0c00424d |
---|---|
record_format |
Article |
spelling |
doaj-f4156899011c453a9c5ad18e0c00424d2021-05-02T11:17:34ZengAdis, Springer HealthcareNeurology and Therapy2193-82532193-65362020-04-019115917110.1007/s40120-020-00189-1Pathway Analysis for Plasma β-Amyloid, Tau and Neurofilament Light (ATN) in World Trade Center Responders at MidlifeMinos Kritikos0Sean A. P. Clouston1Erica D. Diminich2Yael Deri3Xiaohua Yang4Melissa Carr5Sam Gandy6Mary Sano7Evelyn J. Bromet8Benjamin J. Luft9Department of Family, Population and Preventive Medicine, Program in Public Health, Renaissance School of Medicine at Stony BrookDepartment of Family, Population and Preventive Medicine, Program in Public Health, Renaissance School of Medicine at Stony BrookDepartment of Family, Population and Preventive Medicine, Program in Public Health, Renaissance School of Medicine at Stony BrookDepartment of Medicine, Renaissance School of Medicine at Stony BrookDepartment of Medicine, Renaissance School of Medicine at Stony BrookWorld Trade Center Health and Wellness Program, Department of Medicine, Renaissance School of Medicine at Stony BrookDepartment of Neurology, Icahn School of Medicine at Mount SinaiDepartment of Psychiatry, Icahn School of Medicine at Mount Sinai, NYCDepartment of Psychiatry, Renaissance School of Medicine at Stony BrookWorld Trade Center Health and Wellness Program, Department of Medicine, Renaissance School of Medicine at Stony BrookAbstract Introduction World Trade Center (WTC) responders who aided in the search and rescue efforts are now at midlife, and evidence has demonstrated that many are experiencing early-onset cognitive impairment and are at risk of developing dementia, such as Alzheimer’s disease (AD). According to the recent NIA-AA framework, AD is characterized by a neuropathological cascade commencing with β-amyloid deposition (A), followed by tauopathy (T) and neurodegeneration (N). However, the ATN model has not been replicated utilizing recently validated plasma-based biomarkers, and the role of the Aβ40 subtype in A is not well understood. This study examined plasma-based neuropathological markers of Aβ42 and Aβ40 for A, total tau for T, and NfL for N in a cohort of World Trade Center responders at midlife in order to determine the role for the two β-amyloid subtypes in the ATN model. Methods Ultrasensitive Simoa technology was utilized to measure neuropathology in plasma collected from a consecutive clinical sample (n =398). Generalized structural equation modeling was utilized for modeling linkages between pathological markers. Model fit was utilized to determine proposed directions of association. Results Our findings support the ATN neuropathological cascade model of AD and further identify an associative role for Aβ40 in A as playing a central role linking T to N. A strong correlation was found between CI and age, and it was found that women may be at increased risk of elevated T levels, with plasma NfL levels higher in responders with CI. Notably, our model reported associations between: Aβ42, CI and N; Aβ40, T and N; T and CI; Aβ42 and Aβ40. Conclusions The current ATN model of AD does not specify the subtype of β-amyloid to be considered, which may be overlooking the differential roles that these two subtypes serve in the pathogenesis of AD.https://doi.org/10.1007/s40120-020-00189-1Alzheimer’s diseaseATNβ-AmyloidCognitive impairmentDementiaTau |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Minos Kritikos Sean A. P. Clouston Erica D. Diminich Yael Deri Xiaohua Yang Melissa Carr Sam Gandy Mary Sano Evelyn J. Bromet Benjamin J. Luft |
spellingShingle |
Minos Kritikos Sean A. P. Clouston Erica D. Diminich Yael Deri Xiaohua Yang Melissa Carr Sam Gandy Mary Sano Evelyn J. Bromet Benjamin J. Luft Pathway Analysis for Plasma β-Amyloid, Tau and Neurofilament Light (ATN) in World Trade Center Responders at Midlife Neurology and Therapy Alzheimer’s disease ATN β-Amyloid Cognitive impairment Dementia Tau |
author_facet |
Minos Kritikos Sean A. P. Clouston Erica D. Diminich Yael Deri Xiaohua Yang Melissa Carr Sam Gandy Mary Sano Evelyn J. Bromet Benjamin J. Luft |
author_sort |
Minos Kritikos |
title |
Pathway Analysis for Plasma β-Amyloid, Tau and Neurofilament Light (ATN) in World Trade Center Responders at Midlife |
title_short |
Pathway Analysis for Plasma β-Amyloid, Tau and Neurofilament Light (ATN) in World Trade Center Responders at Midlife |
title_full |
Pathway Analysis for Plasma β-Amyloid, Tau and Neurofilament Light (ATN) in World Trade Center Responders at Midlife |
title_fullStr |
Pathway Analysis for Plasma β-Amyloid, Tau and Neurofilament Light (ATN) in World Trade Center Responders at Midlife |
title_full_unstemmed |
Pathway Analysis for Plasma β-Amyloid, Tau and Neurofilament Light (ATN) in World Trade Center Responders at Midlife |
title_sort |
pathway analysis for plasma β-amyloid, tau and neurofilament light (atn) in world trade center responders at midlife |
publisher |
Adis, Springer Healthcare |
series |
Neurology and Therapy |
issn |
2193-8253 2193-6536 |
publishDate |
2020-04-01 |
description |
Abstract Introduction World Trade Center (WTC) responders who aided in the search and rescue efforts are now at midlife, and evidence has demonstrated that many are experiencing early-onset cognitive impairment and are at risk of developing dementia, such as Alzheimer’s disease (AD). According to the recent NIA-AA framework, AD is characterized by a neuropathological cascade commencing with β-amyloid deposition (A), followed by tauopathy (T) and neurodegeneration (N). However, the ATN model has not been replicated utilizing recently validated plasma-based biomarkers, and the role of the Aβ40 subtype in A is not well understood. This study examined plasma-based neuropathological markers of Aβ42 and Aβ40 for A, total tau for T, and NfL for N in a cohort of World Trade Center responders at midlife in order to determine the role for the two β-amyloid subtypes in the ATN model. Methods Ultrasensitive Simoa technology was utilized to measure neuropathology in plasma collected from a consecutive clinical sample (n =398). Generalized structural equation modeling was utilized for modeling linkages between pathological markers. Model fit was utilized to determine proposed directions of association. Results Our findings support the ATN neuropathological cascade model of AD and further identify an associative role for Aβ40 in A as playing a central role linking T to N. A strong correlation was found between CI and age, and it was found that women may be at increased risk of elevated T levels, with plasma NfL levels higher in responders with CI. Notably, our model reported associations between: Aβ42, CI and N; Aβ40, T and N; T and CI; Aβ42 and Aβ40. Conclusions The current ATN model of AD does not specify the subtype of β-amyloid to be considered, which may be overlooking the differential roles that these two subtypes serve in the pathogenesis of AD. |
topic |
Alzheimer’s disease ATN β-Amyloid Cognitive impairment Dementia Tau |
url |
https://doi.org/10.1007/s40120-020-00189-1 |
work_keys_str_mv |
AT minoskritikos pathwayanalysisforplasmabamyloidtauandneurofilamentlightatninworldtradecenterrespondersatmidlife AT seanapclouston pathwayanalysisforplasmabamyloidtauandneurofilamentlightatninworldtradecenterrespondersatmidlife AT ericaddiminich pathwayanalysisforplasmabamyloidtauandneurofilamentlightatninworldtradecenterrespondersatmidlife AT yaelderi pathwayanalysisforplasmabamyloidtauandneurofilamentlightatninworldtradecenterrespondersatmidlife AT xiaohuayang pathwayanalysisforplasmabamyloidtauandneurofilamentlightatninworldtradecenterrespondersatmidlife AT melissacarr pathwayanalysisforplasmabamyloidtauandneurofilamentlightatninworldtradecenterrespondersatmidlife AT samgandy pathwayanalysisforplasmabamyloidtauandneurofilamentlightatninworldtradecenterrespondersatmidlife AT marysano pathwayanalysisforplasmabamyloidtauandneurofilamentlightatninworldtradecenterrespondersatmidlife AT evelynjbromet pathwayanalysisforplasmabamyloidtauandneurofilamentlightatninworldtradecenterrespondersatmidlife AT benjaminjluft pathwayanalysisforplasmabamyloidtauandneurofilamentlightatninworldtradecenterrespondersatmidlife |
_version_ |
1721492463781150720 |